Novozymes is branching further into the U.S. biological market with the purchase of EMD/Merck Crop BioScience. David Fox, Novozymes marketing manager, explains why there's a growth in the biologicals for the farm market....More
Independent seed companies will have access to Syngenta soybean germplasm through GreenLeaf Genetics.
The varieties initially offered will combine Syngenta soybean genetics with the Genuity Roundup Ready 2 Yield trait. Independent seed companies will be able to plant these initial varieties for testing and production in 2011. Companies will be required to have a Genuity Roundup Ready 2 Yield license from Monsanto....More